Search results

Page results

• Patient Advice and Liaison Service (PALS)

  The Patient Advice and Liaison Service (PALS) provides impartial advice and assistance in answering questions and resolving concerns that patients, their relatives, friends and carers might have accessing the NHS services provided by UCLH.

• Genomics England drives sickle cell research through the diverse data initiative

  We are excited to share news that Genomics England has launched an initiative that will directly benefit patients from underrepresented populations such as those living with sickle cell disorder.

• UCLH welcomes new clinical nurse specialist appointed to support asbestos-related cancer patients

  Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area. 

• What is Thrombotic Thrombocytopenia Purpura (TTP)?

  Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.

• Award for researcher behind first treatment for rare disease

  Read more about the award for researcher behind first treatment for rare disease

• Bites, Stings & Animal Related Injuries Service: Hospital for Tropical Diseases

  The bites, stings, and animal-related injury service at the Hospital for Tropical Diseases offers high-quality, specialised treatment, care, and expert advice to adult patients who have experienced animal or plant-related injuries.

• Series No 28 - Gyanaecological bowel preparation

  This page is for patients who are about to start a course of radiotherapy to the pelvis for a gynaecological cancer.

• NHS patients to benefit from state-of-the-art diagnostic tests for Parkinson’s & Mitochondrial diseases, resulting from a UK-first partnership

  Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).

• Launch of National Education Course for Sickle Cell Disorder

  A groundbreaking e-learning course dedicated to improving care and understanding of Sickle Cell Disorder (SCD) has been officially launched, marking a significant milestone in the fight against health inequalities.

• Dr Jonathan Broomberg, non-executive director

  Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.